Skip to content
★ Sign in to follow
IS

Ira Scott Greenspan

Board Director
Président du Conseil
Scopus BioPharma Inc.
Total declarations
29
Companies
2
▲ Purchases (22 ops.)
€102k
▼ Sales (2 ops.)
€458k

Latest filing published 30 Aug 2021 for Scopus BioPharma Inc., €460.

Filing timeline

BuySale
Ira Scott Greenspan

Insider track record

Disclosed buys
22
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-45.2%

Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Ira Scott Greenspan: trading record in brief

Ira Scott Greenspan, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Scopus BioPharma Inc. and PAVmed Inc. Between 28 April 2016 and 27 August 2021, the trades on record add up to 29 filings.

The open-market side counts 22 purchases for €102k alongside 2 sales for €458k. On balance, insiders were net sellers of €356k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 3 share grants. 2021 to date brings 22 purchases and no sales.

The median purchase comes to €3,437. Of 5 purchases, 5 formed part of a group of insiders buying within 30 days of each other. Purchases made close together by different insiders form what is called a cluster.

The record was last updated on 30 August 2021 with an open-market purchase (€3,346) in Scopus BioPharma Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Ira Scott Greenspan

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ▲
    Executive Committee ChairmanExecutivesScopus BioPharma Inc.
    541 USD33SEC
    110 shares@ US$4.922.7% of flowCommon Stock, par value $0.001SEC:0001104659-21-110764:0
    Canonical exit: 25 Nov 2021 (T+90)
  • ▲
    Executive Committee ChairmanExecutivesScopus BioPharma Inc.
    2,205 USD34SEC
    500 shares@ US$4.4110.9% of flowCommon Stock, par value $0.001SEC:0001104659-21-109182:0
    Canonical exit: 21 Nov 2021 (T+90)
  • ▲
    Executive Committee ChairmanExecutivesScopus BioPharma Inc.
    8,080 USD35SEC
    2,000 shares@ US$4.0440.1% of flowCommon Stock, par value $0.001SEC:0001104659-21-108376:0
    Canonical exit: 17 Nov 2021 (T+90)
  • ▲
    Executive Committee ChairmanExecutivesScopus BioPharma Inc.
    4,130 USD31SEC
    1,000 shares@ US$4.1320.5% of flowCommon Stock, par value $0.001SEC:0001104659-21-107826:0
    Canonical exit: 15 Nov 2021 (T+90)
  • ▲
    Executive Committee ChairmanExecutivesScopus BioPharma Inc.
    5,247 USD30SEC
    1,100 shares@ US$4.7725.8% of flowCommon Stock, par value $0.001SEC:0001104659-21-096344:0
    Canonical exit: 21 Oct 2021 (T+90)

5 of 5 declarations